MGC Pharma to Rebrand to Argent BioPharma, OCT Explores Capital Reorganisation, & Cannabis Poland’s Stock Skyrockets
MGC Pharmaceuticals / Argent BioPharma MGC Pharmaceuticals has become the latest UK-listed cannabis company to opt for a rebrand
MGC Pharmaceuticals / Argent BioPharma MGC Pharmaceuticals has become the latest UK-listed cannabis company to opt for a rebrand
Chill Brands Chill Brands published a ‘trading update’ to investors this morning, revealing growth in a number of key
MGC Pharmaceuticals MGC Pharmaceuticals announced this week that it has now secured ‘binding commitments’ for US$7.9m in investment, which
MGC Pharmaceuticals MGC Pharmaceuticals, which became the first cannabis company to list on the London Stock Exchange (LSE) in
MGC Pharmaceuticals MGC Pharmaceuticals announced the closure of its share purchase plan (SPP) this week, seeing the company successfully
MGC Pharmaceuticals MGC Pharmaceuticals released a flurry of updates over the last week, announcing plans to launch a A$2.7m
Cantourage German-listed cannabis distributor Cantourage informed investors this week that it expects to see ‘double digit’ sales growth and
Cellular Goods Cellular Goods has issued a long-awaited update to investors regarding its recent acquisition of carbon sequestration company
Ananda Developments Aquis Stock Exchange-listed Ananda Developments has seen its stock jump by nearly 20% over the last week following
MGC Pharmaceuticals Ltd (“MGC Pharma”, “MGC” or the “Company”) a European based pharmaceutical company specialising in the production and development
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.